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Abstract The physiological characterstics of 
 
allo
 
-cholic acid
(ACA), a typically fetal bile acid that reappears during liver
 
regeneration and carcinogenesis were investigated. [
 
14
 
C] Tauro-
 
ACA (TACA) uptake by Chinese hamster ovary cells ex-
pressing rat organic anion transporter polypeptide (Oatp)1
or sodium-taurocholate cotransporter polypeptide (Ntcp) was
lower than that of [
 
14
 
C]taurocholic acid (TCA). Although
TACA inhibited ATP-dependent TCA transport across
plasma membrane vesicles from Sf9 cells expressing rat or
mouse bile salt export pump (Bsep), no ATP-dependent
TACA transport was found. In rats, TACA was secreted into
bile with no major biotransformation and it had lower clear-
ance and longer half-life than TCA. In mice, TACA bile output
was lower (
 

 
50%) than that of TCA, whereas TACA in-
duced 9-fold higher bile flow than TCA. Even though the in-
tracellular levels were lower for TACA, translocation into
the hepatocyte nucleus was higher for TACA than for TCA;
 
however, rate of DNA synthesis, expression levels of
 

 
-fetoprotein, albumin, Ntcp, and Bsep, cell viability, and
apoptosis in rat hepatocytes were similarly affected by both
isomers. In conclusion, TACA partly shares hepatocellular
uptake system(s) for TCA.  Furthermore, in contrast to
other “flat” bile acids, TACA is efficiently secreted into bile
via transport system(s) other than Bsep and is highly choleretic,
hence its appearance during certain situations may prevent
accumulation of cholestatic precursors.—
 
Mendoza, M. E.,
 
M. J. Monte, M. A. Serrano, M. Pastor-Anglada, B. Stieger, P. J.
Meier, M. Medarde, and J. J. G. Marin.
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Major bile acids (BAs) are mono or polyhydroxylated
acidic steroids with a 5
 

 
-cholanoyl structure in which the
A and B rings are approximately perpendicular; however,
minor BAs with unsaturations affecting C5 or with a 5
 

 
-
cholanoyl configuration (
 
allo
 
-BA) have both rings on the
same plane, explaining their designation as “flat” BAs.
They are uncommon in healthy adult mammals, but are
 
present in fetuses as well as in lower species. For example,
in some migratory species of fishes, such as 
 
Petromyzon
marinus, allo
 
-BAs are strong specific stimulants of the ol-
factory epithelium (1). These BAs may play an important
role as conspecific migratory pheromones produced by lar-
vae to attract adult individuals towards reproductive areas
upstream in the river (2).
 
Allo
 
-BAs were first described at the beginning of the
previous century and little attention has since been paid
to the physiological characteristics of these BAs in mam-
mals (3). Because the cholestatic properties of other BAs
that share with 
 
allo
 
-BAs their flat structure have been de-
scribed and the molecular bases of this effect have been
studied (4), the first objective of the current study was to
investigate the liver handling of 
 
allo
 
-cholic acid (ACA)
(see structure in the inset of 
 
Fig. 1
 
).
Flat BAs reappear in both adult humans and in the rat
during physiological and pathophysiological liver cell pro-
liferation. They are easily detected in the serum and even
more easily in the urine, presumably due to the low ability
of the liver to handle them, in patients with hepatocellular
carcinoma (5). In rats, flat BAs also reappear during hepa-
tocarcinogenesis (6, 7) and are transiently elevated during
the liver regeneration that follows two-thirds partial hepa-
tectomy (8, 9). Whether this is a mere epiphenomenon or
 
allo
 
-BAs play a biological role is unknown. The discovery of
BAs in the nuclei of rat hepatocytes (10) together with the
observation that the composition of this sub-pool of BAs
markedly differs from that of the cytosolic sub-pool (7, 9)
and the fact that important changes occur in the nuclear
sub-pool during liver carcinogenesis (7) and regeneration
(9) suggest that 
 
allo
 
-BAs may be involved in signaling mech-
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anisms related to proliferation, differentiation, viability, or
apoptosis of parenchymal liver cells. We therefore ex-
tended these studies in an attempt to decipher this ques-
tion by investigating the ability of ACA to reach the hepato-
cyte nucleus and to affect the processes mentioned above.
MATERIALS AND METHODS
 
Chemicals
 
Bile acids or sodium salts and methyl cholate (more than 95%
pure by TLC), taurine, 3
 

 
-hydroxysteroid dehydrogenase, sulfatase,
 

 
-glucuronidase, cholylglycine hydrolase, Hoechst-33258, neutral
red, culture media, supplements, and antibiotics for hepatocyte
and cell line cultures were from Sigma-Aldrich (Madrid, Spain).
G418-sulfate (Geneticin) and fetal calf serum were from Boeh-
ringer Manheim (Barcelona, Spain). [
 
14
 
C]Taurocholic acid
(TCA, specific activity 49 mCi/mmol), [
 
3
 
H]TCA (specific activity
3 Ci/mmol), [
 
14
 
C]taurine (specific activity 108.5 mCi/mmol)
and [methyl-
 
14
 
C]thymidine (specific activity 57 mCi/mmol)
were from PerkinElmer Life Science (Pacisa & Giralt, Madrid,
Spain). 3
 

 
,7
 

 
,12
 

 
-trihydroxy-5
 

 
-cholanoic acid (ACA) was syn-
thesized from methyl ester (9% yield) by the method described by
Iida et al. (11). The trimethylsilyl ether derivative of methyl-ACA was
prepared and analyzed by gas-chromatography mass-spectrome-
try tandem (GC-MS) (5) using commercial ACA (Toronto Re-
search Chemicals, Ontario, Canada) as standard. Both the reten-
tion-times in GC (data not shown) and mass spectra (
 
Fig. 2
 
) were
consistent with the assigned identity of the product. The purity
was approximately 99%. The radiolabeled derivative [
 
14
 
C]tauro-
 
allo
 
-cholic acid (TACA) (259 
 

 
Ci/mmol specific activity) was ob-
tained by conjugating ACA with [
 
14
 
C]taurine (12). [
 
14
 
C]TACA was
purified to more than 98% by liquid-solid extraction in octa-
decylsilane cartridges followed by preparative TLC. Intermediate
compounds in the reactions and the final products were dis-
solved in CDCl3 and characterized by proton nuclear magnetic
resonance (
 
1
 
H-NMR) at 200 MHz using tetramethylsilane as in-
ternal standard. Figure 1 depicts the 
 
1
 
H-NMR spectrum for the
methyl-ACA, indicating the most characteristics signals. The
characteristic shifts (
 

 
) for methyl-ACA and TACA: the hydro-
gens in 
 

 
 disposition geminal to the 
 

 
-hydroxyl groups on three,
seven, and 12 and the methyl groups (18, 19, and 21), as well as
 
the taurine methylenes 25 and 26, are shown in 
 
Table 1
 
. More-
over, as expected, the signal corresponding to the hydrogen
geminal to the 3
 

 
-hydroxyl changed from a broad multiplet (ax-
ial disposition) in cholic acid (CA) (data not shown) to a narrow
multiplet (equatorial disposition) in ACA (Fig. 1).
 
In vitro studies on TACA transport
 
Chinese hamster ovary (CHO) cells that had previously been
stably transfected with the cDNA for rat sodium-taurocholate
cotransporter polypeptide (Ntcp) (13) or organic anion trans-
porter polypeptide (Oatp1) (14) and wild-type CHO cells were
used in uptake studies. Cells were grown in DMEM supple-
mented with 10% fetal calf serum, 2 mM 
 
l
 
-glutamine, 50 
 

 
g/ml
 
l
 
-proline, 100 U/ml penicillin, 100 
 

 
g/ml streptomycin, and 0.5
 

 
g/ml amphotericin B at 37
 

 
C in an atmosphere of 5% CO
 
2
 
-95%
air. Selective media contained additional 400 
 

 
g/ml geneticin.
The expression of above-mentioned carriers was induced by in-
cubating the transfected cells for 24 h with culture medium
supplemented with 5 mM butyrate (15).
Once grown to confluence on 60 mm diameter dishes, the cells
were rinsed three times with pre-warmed (37
 

 
C) sodium- or choline-
containing Earle’s balanced saline solution supplemented with 5.5
mM 
 
d
 
-glucose. Cells were then incubated at 37
 

 
C in the presence
of 20 
 

 
M [
 
14
 
C]TACA or [
 
14
 
C]TCA for 15 min. Transport was
Fig. 1. 1H-NMR spectrum of allo-cholic acid methyl ester (methyl-ACA) showing the most characteristic sig-
nals. The inset depicts the structure of the 5 (ACA) and 5 (CA) epimers of cholic acid.
Fig. 2. Mass spectrum of the trimethyl silyl derivative of ACA (methyl
ester) subjected to gas-chromatography mass-spectroscopy tandem
(GC-MS).
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stopped with 2 ml of ice-cold sodium- or choline-containing
Earle’s solution. After two additional washing steps with stop so-
lution, the cells were digested in 1 ml Lowry solution (100 mM
NaOH, 189 mM Na
 
2
 
CO
 
3
 
) for 2 h. Cells were harvested by scrap-
ing to measure radioactivity and total protein concentrations.
Plasma membrane vesicles from insect Sf9 cells expressing rat or
mouse bile salt export pump (Bsep) were obtained as previously
described (16, 17). Vesicles were incubated with [
 
3
 
H]TCA,
[
 
14
 
C]TACA, or both in the absence or in the presence of 5 mM ATP
plus an ATP regenerating system (3 mM phosphocreatine plus 100
 

 
g/ml creatine phosphokinase) for 20 min, and uptake was
stopped using a rapid filtration technique, as previously described
(17, 18). The study was carried out at a high substrate concentration
(100 
 

 
M) in order to increase the radioactivity retained by the vesi-
cles on the filters up to an accurate level. Additionally, to accom-
plish this it was necessary to count three filters together.
 
In vivo studies
 
Non-fasting male and 21-day pregnant Wistar CF rats and male
Swiss Albino mice were from the Animal House at the University of
Salamanca, Spain. They were fed on commercial pelleted rat or
mouse food (Panlab, Madrid, Spain) and water ad libitum. Tem-
perature (20
 

 
C) and the light/dark cycle (12 h:12 h) in the
room were controlled. All animals received humane care as out-
lined in the “Guide for the Care and Use of Laboratory Animals”
(National Institutes of Health Publication No. 8023, revised
1985). Surgery and bile collections were carried out under so-
dium pentobarbital (Nembutal N.R., Abbot, Madrid, Spain) an-
esthesia (50 
 

 
g/g bwt, ip). Flexible catheters were inserted into
the left carotid artery to collect blood samples and into the left
jugular vein to administer BAs. The common bile duct was also
cannulated to collect bile samples. In mice, the gallbladder was
ligated. After administration of a single iv bolus of [
 
14
 
C]TACA or
[
 
14
 
C]TCA, blood (in rats) and bile (in rats and mice) samples
were collected at the indicated time-points.
In some experiments, a single dose of 10 nmol/g bwt [
 
14
 
C]TACA
was injected through the penis vein to rats under ether anesthesia.
The animals were allowed to recover from anesthesia in a warmed
cabinet and were then housed in individual metabolic cages where
they had free access to food and water. Six hours after TACA admin-
istration, a blood sample was obtained from the tail vein. Serum was
 
ultrafiltered using 10 kD cut-off filters (Amicon Micricon-10, Lex-
ington, MA). Urine samples were collected for 14 days. After this
time, animals were anesthetized with sodium pentobarbital and sur-
gically prepared as described above to collect bile samples over 8 h
(at 1 h intervals) in order to obtain most of the bile acid pool.
 
Nuclear translocation, differentiation, proliferation,
viability, and apoptosis
 
Translocation of [
 
14
 
C]TACA or [
 
3
 
H]TCA into the nucleus of
adult rat hepatocytes that were isolated by two-steps collagenase
method (19) was measured as previously described (9). The de-
gree of differentiation was studied in 21 days fetal liver cells
freshly after isolation (20) or after 2 or 4 days in primary culture
in the presence of none, 10 
 

 
M, or 50 
 

 
M ACA, CA, or ursode-
oxycholic acid (UDCA). Purification of total RNA was performed
using the RNAeasy mini kit from Quiagen (Izasa, Barcelona,
Spain), following the instructions supplied by the vendor. RNA
quality was determined by denaturing formaldehyde agarose gel
electrophoresis and the amount was measured spectrophotomet-
rically at 260 nm. Northern blot was performed using 20 
 

 
g of
denatured RNA, which was size-fractionated by agarose gel elec-
trophoresis. The fractionated RNA was transferred onto a nylon
membrane (Biodyne B; Pall Gelman Sciences, Barcelona, Spain)
and successively probed with rat Bsep, Ntcp, albumin, and
 

 
-fetoprotein (
 

 
FP) cDNAs under high stringency conditions using
ExpressHyb hybridization solution from Clontech (BD, Madrid,
Spain). 
 

 
-actin cDNA was used as an internal calibrator for com-
parative purposes among the different experimental conditions.
The effect on proliferation, cell viability and apoptosis was de-
termined in adult rat hepatocytes in primary culture. Cells in
Williams’ medium E, pH 7.4, were seeded at 
 

 
10
 
4
 
 cells/cm
 
2
 
 and
cultured for 24 h as previously reported (21). The medium was
then replaced by fresh one that contained 10 
 

 
M or 50 
 

 
M ACA,
CA, or UDCA. Cells plated in the presence 0.1% DMSO were
used as controls. At 69 h after seeding, [
 
14
 
C]thymidine (50,000
dpm/plate) was added. Three hours later, plates were washed
twice with PBS and cells were detached with Lowry solution in or-
der to measure total DNA, protein, and radioactivity. Toxicity was
determined at the end of the exposure period by the neutral red
retention test, as previously described (21).
The pro-apoptotic effect of ACA was evaluated using four differ-
ent approaches. In a first attempt, apoptosis measurements were
carried out by the detection of histone-associated DNA fragments
using a Cell Death Detection ELISA kit (Roche, Barcelona).
Because even the positive control used in these experiments, i.e.,
glycochenodeoxycholic acid (GCDCA), did not induce a strong
pro-apoptotic effect, additional experimental design and evaluation
methods were used. Freshly isolated hepatocytes were plated, and
after a 1.5 h attachment period they were exposed to 100 
 

 
M ACA,
CA, or GCDCA for 4 h before carrying out morphological evalua-
tion of apoptosis by: 
 
i
 
) staining of nuclei with Hoechst-33258
(5 
 

 
g/ml, 20 min in the dark) in 4% paraformaldehyde-fixed cells,
followed by fluorescence microscopy to visualize condensed chro-
matin as well as nuclear fragmentation (22); 
 
ii
 
) DNA extraction and
electrophoresis in 1.5% agarose gels to assess DNA ladder forma-
tion (23, 24); and
 
 iii
 
) single cell electrophoresis (comet) assays (25).
 
Analytical methods
 
Bile flow was determined gravimetrically. Radioactivity in bile,
total serum, ultrafiltered serum, urine, cell extracts, and isolated
nuclei was measured on a Beckman LS-6500 liquid scintillation
counter (Beckman Instruments, Madrid, Spain) using Universol
Scintillation Cocktail from ICN (Biolink, Barcelona, Spain). The
concentrations of 3
 

 
-hydroxyl-BAs in bile were measured enzy-
matically using 3
 

 
-hydroxysteroid dehydrogenase (26). Biotrans-
formation of [
 
14
 
C]TACA was investigated by TLC of BAs extracted
 
TABLE 1.
 
1
 
H-NMR assignments
 
3
 

 
,7
 

 
,12-Trihydroxy-5- Cholanoic Acid Methyl Ester
Groupa Number of H
Shift () 
Multiplicity
3-H 1 4.05 m
7-H 1 3.83 m
12-H 1 3.95 m
18-Me 3 0.68 s
19-Me 3 0.77 s
21-Me 3 0.98 d J 5.4 Hz
COOMe 3 3.66 s
3,7,12-Trihydroxy-5-Cholanoyl-Taurine
3-H 1 3.85 m
7-H 1 3.67 m
12-H 1 3.81 m
18-Me 3 0.59 s
19-Me 3 0.69 s
21-Me 3 0.90 d J 5.4 Hz
25-H 2 2.87 t
26-H 2 3.47 t
 is given in ppm. Tetramethylsilane was used as internal reference.
a Numbering of groups refers to those of positions for C in the
usual bile acid structure of a cholanoic acid. Solvent was CDCl3.
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from bile and urine samples (5) using n-butanol-acetone-acetic
acid-water (35:35:10:20) as eluent. The presence of total ACA in
bile and urine samples was investigated by GC-MS (5) after liquid-
solid extraction, enzymatic desulfation, deglucuronation, and
deamidation (27, 28), and derivatization (29) of BAs. Proteins
were measured using a modification of the Lowry method (30)
with serum bovine albumin as standard. DNA was measured fluo-
rometrically using Hoechst-33258 (31). The rate of DNA synthesis
was determined by [14C]thymidine incorporation into DNA (32).
Pharmacokinetic and statistical analysis
In order to compare the pharmacokinetics of [14C]TACA and
[14C]TCA, model-independent methods based on the theory of
statistical moments were used to analyze data on serum concen-
trations after iv administration of both of these BAs to anesthe-
tized rats. AUCs (areas under the curve) and MRTs (mean resi-
dence times) were calculated by numerical integration using the
trapezoidal rule, as described by Yamaoka et al. (33). Because
this was observed over a limited period of time (120 min), extrapo-
lation to infinity ( ) was carried out using a monoexponential
equation. Clearance (Cl) was calculated as the absolute dose di-
vided by the AUC and the half-life (T1/2) as Ln2/Ke, where Ke (elim-
ination constant) is 1/MRT. Results are expressed as mean 	 SE. To
calculate the statistical significance of the differences, paired or un-
paired Student’s t-tests and the Bonferroni method of multiple-
range testing were used, as appropriate.
RESULTS
TACA uptake, biotransformation, and secretion
Although wild-type CHO cells exhibited low uptake of
TCA, this was not negligible for TACA (Fig. 3). Owing to
the fact that TACA has a structural similarity with steroid
hormones and because CHO cells originiate from a ste-
roidogenic tissue, they may contain intrinsic transport sys-
tems for steroids able to carry out the TACA uptake that
was observed in wild-type CHO cells. Nevertheless, the ex-
pression of Oatp1 or Ntcp by transfected CHO cells was
accompanied by a significant enhancement in TACA up-
take. The expression of these carriers induced Na
-inde-
pendent and Na
-dependent uptake of TCA, respectively
(Fig. 3). TACA uptake was similar to that found for TCA
in Oatp1-expressing CHO cells; however, in Ntcp-express-
ing CHO cells, although TACA uptake was significantly
higher than that seen for wild-type CHO cells, this was not
reduced when Na
 was replaced by choline in the incuba-
tion medium. Experiments carried out on rat or mouse
Bsep-containing plasma membrane vesicles of Sf 9 insect
cells revealed that ATP-dependent transport of TCA was
inhibited by TACA; however, TACA was not transported by
ATP-dependent systems present in these vesicles (Fig. 4).
The results obtained in in vitro experiments were con-
sistent with those found in experiments carried out on in
vivo models. After administration (iv, 4 nmol/g bwt) of TCA
or TACA to anaesthetized rats, the disappearance of
TACA from plasma was slower than that of TCA (Fig. 5).
Pharmacokinetic analysis indicated that TACA clearance was
lower and that it had a longer half-life than TCA (Table 2).
Ultrafiltration of serum samples collected 6 h after iv ad-
ministration of TACA in separate experiments revealed
that 80% of this BA was present in the non-ultrafilterable
fraction, i.e., presumably bound to serum proteins; how-
ever, TACA was rapidly secreted into bile. The total bile
output of TACA (78% of dose administered in 2 h) did
not differ significantly from that of TCA (Table 2). At the
moment of maximum biliary output of 14C, most (94.9 	
1.2% by T.L.C, n  4 animals) of the radioactivity secreted
into bile was found to be non-biotransformed TACA. Free
[14C]taurine accounted for less than 0.5% of this radioac-
tivity. Neither TCA nor TACA induced modifications in
bile flow at the dose given to rats (data not shown). To in-
vestigate the effect of TACA on bile flow, a higher dose of
25 nmol/g bwt was used. Moreover, to reduce the amount
of TACA required to reach this goal, these experiments
were carried out on mice (Fig. 6). The amount of TACA
secreted into bile in the ensuing 3 h (270 	 53 nmol/g
liver, i.e., 58 	 5% of the dose) was approximately half
(P  0.01) that found for CA (492 	 67 nmol/g liver, i.e.,
94 	 3% of the dose; P  0.01). Conversely, the BA-induced
increase in bile flow was much higher for TACA (99.3 	 2.7
l/mol) than for TCA (11.3 	 1.7 l/mol; P  0.001).
Urinary excretion was investigated in conscious rats main-
tained in metabolic cages for two weeks after iv administra-
tion of TACA (10 nmol/g bwt). Recovery of the radioactivity
in urine during this period accounted for 13% of the dose
administered. The urinary output peak (5% of the dose ad-
ministered) was reached at 12 h after administration. TACA
accounted for only 2.5% (by TLC) of the 14C found in urine
at that time. The presence in urine of unconjugated ACA re-
leased from TACA, and hence unlabeled, was investigated in
three animals by GC-MS analysis of urine samples collected
24 h after TACA administration. No unconjugated ACA was
detected in any of these samples. Two weeks after administra-
tion of TACA, rats were anesthetized in order to collect as
Fig. 3. Uptake of [14C]taurocholic acid (TCA) and [14C]tauro-allo-
cholic acid (TACA) by CHO cells either of wild-type or stably ex-
pressing the rat carriers sodium-taurocholate cotransporter poly-
peptide (Ntcp) or organic anion transporter polypeptide (Oatp)1.
Cells were incubated with 20 M of one of the radiolabeled bile ac-
ids in medium containing either 116 mM NaCl (Na
-bars) or cho-
line-Cl (Chol-bars) for 15 min at 37C. Values are means 	 SE from
four experiments (carried out in triplicate each). Comparisons
were carried out by the Bonferroni method of multiple range test-
ing. * P  0.05, as compared to wild-type cells; † P  0.05, as com-
pared to uptake of TCA under similar conditions.
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much as possible of the whole BA pool by bile drainage and
to measure the proportions of TACA and ACA. The BA pool
size, determined as the cumulated biliary output of 3-
hydroxyl-BAs for 8 h, was 12.8 	 0.1 mol/g liver (n  3
rats). [14C]TACA identified by TLC was 1.16 	 0.07 nmol/g
liver; i.e. less than 0.01% of the total BA pool. The presence
of total (conjugated with [14C]taurine plus non-amidated)
ACA in these bile samples accounted for 0.27% of total BAs
as determined by GC-MS.
Determination of biological effects
Translocation into the nuclei of freshly isolated rat
hepatocytes in suspension was much higher for TACA
than for TCA, even though the intracellular level of the
former BA was much lower than that of the latter (Fig. 7).
Because of this characteristic and its transient reappear-
ance during liver growth, several potential biological ef-
fects of ACA were investigated; namely, the ability to affect
hepatocyte differentiation, proliferation, cell viability, and
apoptosis. The expression level of proteins typical of adult
hepatocytes, such as albumin and the BA carriers Ntcp
and Bsep and that of a protein typical of fetal parenchymal
liver cells, such as FP, were used as an indication of the
level of hepatic differentiation. Figure 8 shows that even
though the RNA loaded was lower in the case of adult hepa-
tocytes (lane 1), as indicated by the amount of -actin, the
amounts of mRNA for albumin, Ntcp, and Bsep were mark-
edly high. Freshly isolated fetal hepatocytes also contained
high amounts of mRNA for these proteins, including FP,
which was not detected in adult hepatocytes. A decrease
in the expression level of these four proteins was observed
after 2 days in culture. This was slight for albumin and
FP, but very marked for Ntcp and Bsep. A partial recov-
ery in the expression level for all three proteins was ob-
served at 4 days. The presence of CA, ACA, or UDCA at 10
M (data not shown) or 50 M (Fig. 8) had no percepti-
ble effect at 2 or 4 days on the amount of these proteins,
except that Bsep that was higher both at 2 or 4 days in
hepatocytes incubated with CA or ACA.
No ability of ACA to affect rat hepatocyte proliferation was
found. The amount of DNA in the culture of adult rat hepa-
tocytes increased up to 200% after 72 h either in the ab-
sence or the presence of ACA, CA, or UDCA (Table 3). This
was consistent with the absence of significant BA-induced ef-
fects on the rate of DNA synthesis (Table 3). To determine
toxic and pro-apoptotic effects, an additional BA with well-
known abilities in this respect, glycochenodeoxycholic acid
Fig. 4. Uptake of [3H]TCA and [14C]TACA separately or together by plasma membrane vesicles obtained
from insect Sf9 cells expressing rat or mouse bile salt export pump (Bsep). Membrane vesicles were incubated
with 100 M of one or both of the radiolabeled bile acids in the absence or in the presence of 5 mM ATP
plus an ATP regenerating system (3 mM phosphocreatine plus 100 g/ml creatine phosphokinase) for 20
min at 37C. Values are means 	 SE from three experiments (carried out in triplicate each). * P  0.05, as
compared to uptake in absence of inhibitor in similar conditions by paired Student’s t-test.
Fig. 5. Time-course of serum bile acid concentration in rats fol-
lowing intravenous administration of 4 nmol/g bwt of [14C]TACA
or [14C]TCA. Blood was collected at the indicated times from the
carotid artery and radioactivity in serum was measured. Values are
means 	 SE from four animals in each group. **P  0.01, signifi-
cantly different by Student’s t-test.
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(GCDCA), was included in the study as a positive control. At
high concentrations GCDCA, but not ACA or CA, was found
to reduce cell viability (Table 3). GCDCA, but not ACA or
CA, also induced the release of mono- or oligo-nucleosomes
(Table 3) and significantly increased the proportion of apop-
totic cells (Fig. 9, Table 3). As revealed by DNA-ladder forma-
tion in agarose gel electrophoresis and comet assays, DNA
fragmentation was evident in GCDCA-treated cells but was
very weak in hepatocytes incubated with CA or ACA (Fig. 9).
DISCUSSION
Biliary secretion
The ability of flat BAs of the unsaturated type to inhibit
secretion into bile of major BAs might account for their
deleterious effect in several liver diseases in which their in-
creased level has been partly associated with the cause of
cholestatic symptoms in these patients (4). However, our
results indicate that, although TACA is also able to inhibit
TCA transport by rat or mouse Bsep, while itself is not a
substrate for this carrier, TACA induced a stronger choler-
etic effect than TCA. This was probably due to the fact
that TACA was efficiently eliminated from the hepatocytes
into bile. It must be kept in mind that TACA is synthesized
by hepatocytes, hence its first and major route will be
canalicular secretion before it enters enterohepatic circu-
lation. Nevertheless, the contribution of this BA to bile
formation, in the situations where it appears, is probably
minor. Thus, considering the amount of TACA secreted
into bile at the time of rat liver regeneration when such se-
cretion is maximal, i.e., 3 days after partial hepatectomy
(9), and assuming that the ability to induce bile flow is
similar to that seen in intact animals, an assumption that
probably involves a moderate under-estimation (34), it
can be calculated that the contribution of TACA to bile
formation would be approximately 10 nl/min/g liver, i.e.,
lower than 0.5% of total bile flow. Although this may seem
TABLE 2. Elimination into bile and pharmacokinetic parameters from serum concentrations 
curves obtained in anesthetized rats
Serum Bile
AUC Cl MRT T1/2 Output Output
mol/l/min ml/min min min nmol/g liver % of dose
TACA 622.8 	 36.5 1.62 	 0.09 49.3 	 6.8 11.9 	 2.3  86.2 	 2.3 78.0 	 4.4
TCA 412.0 	 3.1b 2.43 	 0.02c 4.4 	 1.9b 3.03 	 1.3a  80.4 	 3.5 72.5 	 4.7
AUC, area under the curve; Cl, clearance (dose/AUC); MRT, mean residence time; T1/2, half-life (MRT.Ln2).
Values are means 	 SD from four experiments in each group, in which following intravenous administration of 4
nmol/g bwt of [14C]TACA or [14C]TCA to anaesthetized rats blood and bile samples were collected at the times in-
dicated in Fig. 5. Statistical moments of the serum concentration curves were calculated by extrapolation to infin-
ity. Statistical significance compared to TACA by Student’s t-test.
a P  0.05.
b P  0.01.
c P  0.001.
Fig. 6. Time-course of bile flow (A) and bile acid output (B) in mice
after intravenous administration of 25 nmol/g bwt of [14C]TACA or
[14C]TCA. Bile was collected 60 min before and 180 min after bile acid
administration (arrow) and radioactivity in bile samples was measured.
Values are means 	 SE from four animals in each group. *P  0.05,
**P  0.01, significantly different by Student’s t-test.
Fig. 7. Translocation of TCA and TACA into the rat hepatocyte
nucleus. Isolated rat hepatocytes were incubated for 60 min with 45
M [3H]TCA and 45 M [14C]TACA before homogenization, nu-
clei isolation, and radioactivity measurement. Bile acid uptake by
hepatocytes (left panel) and bile acid contents in the isolated nu-
clei (right panel) are shown as mean 	 SE of three experiments.
Comparisons (* P  0.05) were carried out by the paired Student’s
t-test. The inset depicts the proportion of each bile acid in whole
cells and in isolated nuclei.
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a poor physiological role, in principle it should not be ne-
glected for the following reason. Allo-BAs are presumably
synthesized from 3-oxo-4-BAs, which are normally trans-
formed into 5-BAs by 3-oxo-4-steroid 5-reductase. In
situations where inappropriate activity of this enzyme or
overproduction of its substrate occurs the transformation
of the cholestatic compounds into a highly choleretic
counterpart, that can be readily eliminated into bile,
might play a role in the protection of the hepatocyte
against the accumulation of toxic products. The activity of
4-steroid 5-reductase, which is normally present in the
liver and is presumably responsible for carrying out this
metabolic transformation also on 4-BAs (35), is probably
only evident under the abnormal circumstances of high in-
tracellular levels of these substrates, as mentioned above.
Liver handling
Observation of the high endogenous ability of wild-type
CHO cells to take up TACA was not a complete surprise
because of the structural similarity of TACA and steroid
hormones and because of the tissue of origin of these
cells, in which steroid hormone exchange across plasma
Fig. 8. Effect of the presence of bile acids in the medium used to culture fetal rat hepatocytes on the
amount of mRNA for albumin, -fetoprotein (FP), Ntcp, and Bsep as determined by Northern blotting of
20 g of total RNA loaded in each lane. The level of -actin in the sample was used as internal calibrator. Fe-
tal rat hepatocytes were cultured for 2 or 4 days in the presence of 50 M ACA, CA, or ursodeoxycholic acid
(UDCA). The level of expression of the indicated genes in freshly isolated adult and fetal hepatocytes was
also determined for comparative purposes.
TABLE 3. Effect of BAs on replication, toxicity, and apoptosis in rat hepatocytes in primary culture
DNA
Thymidine
Incorporation
Neutral Red
Retention
Apoptosis
Index
Apoptotic
Cells
% of initial dpm/g DNA % of control %
Control 201 	 6 275 	 27 100 1 3.8 	 1.9
CA 
10 M 209 	 14 259 	 25 92 	 3 0.90 	 0.15
50 M 208 	 18 281 	 29 93 	 2 0.83 	 0.22
100 M 5.3 	 3.2
ACA 
10 M 207 	 16 319 	 38 93 	 3 0.95 	 0.22
50 M 187 	 13 253 	 20 92 	 4 1.05 	 0.91
100 M 3.3 	 1.9
UDCA 
10 M 182 	 15 327 	 20 89 	 2 0.68 	 0.18
50 M 180 	 16 301 	 21 88 	 4 0.55 	 0.16a
GCDCA
10 M 88 	 6 1.29 	 0.16
50 M 79 	 3a 1.47 	 0.12a
100 M 18.8 	 2.4a
Values are means 	 SE from at least four measurements carried out in triplicate. Total DNA, radiolabeled thy-
midine incorporation into DNA (replication), and neutral red retention (toxicity) were determined in cultures ex-
posed to the indicated BA for 72 h. Nucleosome release (Apoptosis Index) was evaluated after 6 h exposure. The
proportion of apoptotic cells was determined by Hoechst-33258 after exposing the cells to higher BA concentra-
tion for shorter times (4 h).
a P  0.05 as compared to control by paired Student’s t-test.
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membrane is part of their normal function. Moreover, the
ability to take up TACA was enhanced in CHO cells ex-
pressing rat Oatp1, a carrier that also transport steroid
hormones (36). These results suggest that TACA can also
act as a substrate for this liver transporter. With respect to
Nctp, direct measurements of TACA uptake have revealed
efficient uptake by CHO cells transfected with the cDNA of
rabbit Ntcp (37). These findings are partly consistent with
our own results. Indeed, although TACA uptake was en-
hanced in CHO cells expressing rat Ntcp, this transport was
not affected by removal of Na
 from the incubation medium.
Taken the results from in vitro experiments on TACA
transport together, it may be concluded that TACA in part
shares the pathways enabling its entry into the hepatocyte
with major BAs, although in the case of TACA this probably
occurs with lower efficiency. This concept is further sup-
ported by the pharmacokinetic analyses carried out.
Moreover, previously reported finding of a relatively high
abundance of this BA in the urine of patients with hepato-
cellular carcinoma (5) together with the results obtained
in the present work regarding enhanced excretion of this
bile acid and its derivatives in urine after iv administration
to rats are in agreement with a poor liver clearance as
compared with that of its 5-epimer, partially counterbal-
anced by enhanced elimination by the kidney.
Because most of the TACA was found in bile with no
further biotransformation, this BA, rather than any potential
derivative, must be the substrate for a canalicular carrier dif-
ferent from Bsep. The exact identity of the transporter re-
sponsible for canalicular TACA secretion has not been
elucidated in the present work, but it can be suggested
that it could well be the same one as that used by steroid
hormones with a similar flat structure, such as estradiol-
17-d-glucuronide, whose transport across the bile canali-
cular membrane is predominantly mediated by cMOAT/
MRP2 (38). Despite this, however, other isoforms of this
family of proteins can also cooperate in certain cases to
export these compounds from the liver cells (39).
Physiological role
In previous studies we have shown that unconjugated
and conjugated forms of CA have a similar ability to be
translocated into the hepatocyte nucleus, while other hy-
drophilic BAs, such as muricholic acids, are not (7, 9).
Therefore, the existence of specific mechanisms control-
ling the size and composition of the nuclear sub-pool of
BAs was suggested. Other steroids, such as glucocorticoids,
are targeted to the nucleus via a soluble receptor, which
binds them in the cytosol and shuttles them toward the nu-
cleus. Because of the structural similarity between steroid
hormones and allo-BAs, it could be suggested that ACA
might use this kind of pathway for its translocation into the
hepatocyte nucleus, an event that occurs with much greater
efficacy than that of its 5-epimer. The question then arises
as to whether this interesting property of ACA might have
any repercussions in liver physiology. Because this BA ap-
pears during liver growth, a role in the complex concert of
signals controlling liver tissue morphogenesis could be pos-
tulated; however, although such a hypothesis is undoubt-
edly appealing, in our work we were unable to confirm
such a notion with the data available. The ability of ACA to
affect hepatocyte proliferation, differentiation, viability,
and apoptosis was no higher than that of other major BAs
that have protective (40) or deleterious (21, 41) effects and
that are commonly found in the BA pool at much higher
concentrations than those of ACA. Nevertheless, because
for efficient liver growth and shaping to occur there needs
to be an interplay among mitogens, co-mitogens, and dif-
ferentiation signals, which were not investigated in the
present work, and because the list of genes involved in liver
tissue differentiation studied by us was not exhaustive, this
hypothesis cannot yet be ruled out. Moreover, in addition
to a potential effect of ACA on hepatocytes acting in an au-
tocrine manner, the interesting possibility of a paracrine ef-
fect of ACA on liver cells other than hepatocytes was not ad-
dressed either in the present study.
In conclusion, TACA partly shares hepatocellular uptake
system(s) for TCA. Furthermore, in contrast to other flat
BAs, such as 4-BAs and 5-BAs, which are believed to be in
part responsible for the cholestasis observed in some meta-
bolic liver diseases (4), TACA is efficiently secreted into bile
via transport system(s) other than Bsep and is highly
choleretic, hence its appearance during certain situations
may prevent accumulation of cholestatic precursors.
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tracted from hepatocytes of the experimental groups: Control
(lane 2), ACA (lane 3), CA (lane 4), and GCDCA (lane 6). A DNA
molecular weight standard was loaded in lanes 1 and 5. C: Charac-
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